InvestorsHub Logo
Followers 132
Posts 6427
Boards Moderated 0
Alias Born 05/13/2014

Re: Florida_or_bust post# 1027

Monday, 10/05/2020 12:34:20 PM

Monday, October 05, 2020 12:34:20 PM

Post# of 1990
Yeah.... Saw that after the fact LOL... agh. What an interesting incentive package ... Good reason to do more interviews & continue to generate exposure for BPSR Organicell.

Let’s see what they can do from here ;)



https://www.otcmarkets.com/filing/html?id=14418854&guid=jq66Ual6YP2xU3h


On September 23, 2020, the Board amended the Company’s Management and Consultant Performance Plan (“MCPP”), providing for the additional grant of common stock of the Company of 15.0 million, 7.5 million and 15.0 million shares of common stock of the Company, respectively, to each Albert Mitrani, Dr. Mari Mitrani and Ian Bothwell upon such time that the Company’s common stock trades above $0.25 per share, $0.50 per share and $0.75 per share, respectively, for 30 consecutive trading days subsequent to March 31, 2021 and provided such milestone occurs during the term of employment with the Company.

In addition, each of the current executives were granted an additional 7 million shares, which represented the total of all incentive shares to be issued to each executive in connection with the Company obtaining a combined thirteen IND’s and/or eIND’s up through September 23, 2020 and which was provided for under the MCPP as defined milestones (previously described in the Company’s Form 8-K filed on April 30, 2020):

Mr. Albert Mitrani 7,000,000 Shares
Mr. Ian Bothwell 7,000,000 Shares
Dr. Maria Mitrani 7,000,000 Shares
Dr. George Shapiro 7,000,000 Shares

In the future, each of the current executives shall also be entitled to receive 5 million shares as a performance incentive for each IND and/or “Expanded Access” approval (and excluding all eIND’s) received by the Company that involve more than 15 patients and provided such milestone occurs during the term of employment with the Company.

The Company issued the above-referenced Shares under the exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act, as a transaction not involving a public offering.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZEOX News